Teach me to fish.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6392661)

Published in J Emerg Nurs on January 31, 1985

Authors

I Frank

Articles by these authors

Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71

Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med (1996) 2.36

Screening surgeons for HIV infection: assessment of a potential public health program. Infect Control Hosp Epidemiol (1994) 2.03

Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol (1994) 1.88

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clin Infect Dis (2008) 1.81

Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology (1995) 1.74

Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol (1991) 1.73

Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis (1990) 1.69

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. J Infect Dis (1999) 1.67

Surgical treatment of abdominal aortic aneurysms. Surgery (1968) 1.63

Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J Virol (1990) 1.38

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). J Infect Dis (2011) 1.37

Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol (1999) 1.26

Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest (1992) 1.20

Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1997) 1.17

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin Microbiol Infect (2011) 1.15

IL-15 enhances immune functions during HIV infection. J Immunol (1997) 1.13

Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest (1994) 1.13

Poisoning from ingestion of a stramonium-belladonna mixture: flower power gone sour. JAMA (1968) 1.12

Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. Antimicrob Agents Chemother (1986) 1.11

Proliferation of primary sensory neurons in adult rat dorsal root ganglion and the kinetics of retrograde cell loss after sciatic nerve section. Somatosens Res (1985) 1.07

Treatment of cryptosporidiosis with paromomycin. A report of five cases. Arch Intern Med (1992) 1.03

Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology (1993) 1.02

Application of transtracheal pressure oscillations as a modification of "diffusing respiration". Br J Anaesth (1972) 1.00

Nurse practitioner managed care for persons with HIV infection. Image J Nurs Sch (1993) 0.98

Interaction of terbinafine with human serum and serum proteins. J Med Vet Mycol (1992) 0.97

Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients. J Clin Invest (1995) 0.93

Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease. J Clin Invest (1997) 0.90

[Autoantibody detection by indirect immunofluorescence on HEp-2 cells]. Dtsch Med Wochenschr (2009) 0.89

Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers. AJNR Am J Neuroradiol (1994) 0.87

Long-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients. Br J Ophthalmol (1989) 0.86

The keratinocyte-derived cytokine IL-7 increases adhesion of the epidermal T cell subset to the skin basement membrane protein laminin-5. Eur J Immunol (1999) 0.86

Prototheca zopfii isolated from a patient with olecranon bursitis. Diagn Microbiol Infect Dis (1987) 0.85

Complications and initial continence rates after a repeat pubovaginal sling procedure for recurrent stress urinary incontinence. J Urol (2001) 0.85

Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retroviruses (1996) 0.85

Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.85

Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med (1994) 0.85

Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J Virol (1998) 0.84

Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Mol Immunol (1998) 0.83

Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. J Viral Hepat (2013) 0.83

Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers. HIV Med (2007) 0.83

The envelope of HIV. Immunol Lett (1996) 0.81

Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection. Clin Diagn Lab Immunol (1999) 0.81

Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18. Eur J Microbiol Immunol (Bp) (2012) 0.81

[Intrapulmonary gas exchange during simulated apnea due to transtracheal periodic intrathoracic pressure changes]. Anaesthesist (1973) 0.80

Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency. AIDS Res Hum Retroviruses (2005) 0.79

Interleukin-12 in the pathogenesis and therapy of HIV disease. Res Immunol (1996) 0.79

Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro. AIDS Res Hum Retroviruses (2000) 0.79

Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder. Urology (1991) 0.78

Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1). Viral Immunol (1992) 0.78

[Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus]. Z Gesamte Inn Med (1986) 0.78

Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals. Clin Infect Dis (1995) 0.77

A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.77

Light- and electron microscopic investigations of pulmonary tissue after high-frequency positive-pressure ventilation (HFPPV). Anaesthesist (1975) 0.77

Interleukin-2 treatment of microglia has no effect on in vitro HIV infection. AIDS (1999) 0.76

[Test measuring myocardial consistency using transtracheally excited oscillation of the heart caused by pressure changes. I]. Arch Kreislaufforsch (1972) 0.75

Chromophore localization in conjugated polymers: molecular dynamics simulation. J Phys Chem B (2007) 0.75

[Laudation on bestowing of the Hippocrates Medal for Merits in general medicine to E. V. Kuenssberg, M.D. in Igls, 1974]. Z Allgemeinmed (1974) 0.75

Enhancement of CO2-elimination by intrapulmonary high frequency pressure alternation during "apnoeic oxygenation". Adv Exp Med Biol (1978) 0.75

Australian Medical Council: a view from the inside. Intern Med J (2001) 0.75

[Method of trans-tracheal vibration for the induction of periodic intra-ventricular pressure oscillations]. Pflugers Arch (1972) 0.75

[Longterm therapy with anticoagulants]. Z Arztl Fortbild (Jena) (1966) 0.75

[Radioimmunologic determination of serum insulin: experiences with paper-wick chromatography]. Endokrinologie (1972) 0.75

Large perilymph fistulas. Am J Otol (1986) 0.75

[Relaxation-promoting effect of vitamin B with anabolics]. Arzneimittelforschung (1970) 0.75

An analysis of the opinions toward mental health among nurses and physicians in Dekalb County, Illinois. IMJ Ill Med J (1966) 0.75

Comprehensive approach in rural family practice. GP (1967) 0.75

[Transtracheally-induced intraventricular periodic pressure variations: a new diagnostic technic in cardiology]. Verh Dtsch Ges Kreislaufforsch (1972) 0.75

Appropriateness of antiretroviral therapy in clients of an HIV/AIDS case management organization. AIDS Care (2007) 0.75

The necessity for new colleague relationships between professionals. IMJ Ill Med J (1975) 0.75

Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene. FEBS Lett (1986) 0.75

Interpretation of the amplitude modulation profile following trans-tracheally induced intra-ventricular pressure oscillations. Pflugers Arch (1972) 0.75

[Secretion of insulin before and after elimination of Dumping symptoms through transformation surgery]. Dtsch Z Verdau Stoffwechselkr (1974) 0.75

Problems of sexuality as encountered in a general family practice. Psychosomatics (1974) 0.75

[Dosage and duration of the streptokinase treatment in myocardial infarct. Preliminary report]. Folia Haematol Int Mag Klin Morphol Blutforsch (1969) 0.75

Effect of interleukin-12 on the cytokine profile of human CD4 and CD8 T-cell clones. Ann N Y Acad Sci (1996) 0.75

[New items in our laboratory]. Zahntechnik (Berl) (1976) 0.75

[The modification of the effects of calcium on the heart using beta-adrenergic blockers]. Dtsch Tierarztl Wochenschr (1996) 0.75

Iris Frank, administrator, pioneers innovative specialty hospital. Interview by Marlene Jezierski. J Emerg Nurs (1996) 0.75

The management of adolescent crises in family practice. Adolescence (1975) 0.75

[Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels]. Endokrinologie (1969) 0.75

Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients. Am J Med (1992) 0.75

[Delayed effects of calcium]. Dtsch Tierarztl Wochenschr (1994) 0.75

[Acid-base equilibirium and blood circulation following diffusion breathing under optimal vibration]. Pflugers Arch (1972) 0.75

Two-year experience with electro-convulsive therapy in a semi-rural hospital. IMJ Ill Med J (1969) 0.75

The management of the academic under-achiever. Psychosomatics (1970) 0.75